Home » Newsletters » BioWorld

BioWorld

Dec. 19, 2000

View Archived Issues

Correction (Article Updated on Database)

Other News To Note

DNA Sciences Acquiring PPGx To Pool Data, Expertise, Marketing

Aviron Files Shelf Registration For Up To $400M Of Securities

Normal Events In Body May Cause Autoimmune Disease, Wistar Immunologists Show

Magainin Regains IL-9 Rights After Genentech Drops Out

Immunomedics, Amgen Enter NHL Deal Worth Up To $308M

The Medicines Co. Gets Angiomax Approval; Launch Set For January

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...